Salivary alpha-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease. Vivacqua G, Mason M, De Bartolo MI, Wegrzynowicz M, et al. Mov Disord 2022 Oct 19. doi: 10.1002/mds.29246.

Read + Share

Amedeo Smart

Independent Medical Education

Vivacqua G, Mason M, De Bartolo MI, Wegrzynowicz M, et al. Salivary alpha-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease. Mov Disord 2022 Oct 19. doi: 10.1002/mds.29246.
PMID: 36259554